Interventionelle Radiologie Scan, Table of Contents Interventionelle Radiologie Scan 2013; 01(02): 163-180DOI: 10.1055/s-0033-1344192 Fortbildung © Georg Thieme Verlag KG Stuttgart · New YorkCT-gesteuerte Brachytherapie Authors Peter Hass Tina Bretschneider Konrad Mohnike Recommend Article Abstract Buy Article(opens in new window) Full Text References Literatur 1 Steel G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer: Biologic perspective. Ann Surg 1989; 210: 127-138 2 Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989; 124: 1021-1022 3 Popescu I, Alexandrescu S. Hepatic metastases of colorectal cancer – current therapeutic possibilities. Review. Chirurgia (Bucur) 2010; 105 : 155-169 4 Shah K, Clary B. Synchronous colorectal liver metastases: the “surgeon as oncologist” perspective. Minerva Chir 2013; 68: 49-76 5 Ricke J, Wust P, Stohlmann A et al. CT guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: Phase I–II results of a novel technique. Int J Radiat Oncol Bio Phys 2004; 58: 1496-1505 6 Ricke J, Mohnike K, Pech M et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate Brachytherapy. Int J Radiat Oncol Biol Phys 2010; 78: 479-485 7 Mohnike K, Wieners G, Schwartz F et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy and effect on survival. Int J Radiat Oncol Biol Phys 2010; 78: 172-179 8 Collettini F, Schnapauff D, Poellinger A et al. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (> 7 cm) tumors. Eur Radiol 2012; 22: 1101-1109 9 Collettini F, Golenia M, Schnapauff D et al. Percutaneous computed tomography-guided high-dose-rate Brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. J Vasc Interv Radiol 2012; 23: 618-626 10 Wieners G, Mohnike K, Peters N et al. Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy – a phase II-study. Radiother Oncol 2011; 100: 314-319 11 Peters N, Wieners G, Pech M et al. CT-guided interstitial brachytherapy of primary and secondary lung malignancies. Results of a prospective phase II trial. Strahlenther Onkol 2008; 184: 296-301 12 Collettini F, Schnapauff D, Poellinger A et al. Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates. Rofo 2012; 184: 316-323 13 Wieners G, Pech M, Rudzinska M et al. CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 2006; 16: 2586-2593 14 Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008; 3: 36 15 Rusthoven KE, Kavanagh BD, Cardenes H et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy (SBRT) for liver metastases. J Clin Oncol 2009; 27: 1572-1578 16 Ricke J, Wust P, Stohlmann A et al. Eine neue perkutane Technik zur interstitiellen Ablation von Lebermetastasen. Strahlenther Onkol 2004; 5: 274-280 17 Ricke J, Wust P, Stohlmann A et al. CT guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: Phase I–II results of a novel technique. Int J Radiat Oncol Bio Phys 2004; 58: 1496-1505 18 Ricke J, Wust P, Wieners G et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004; 15: 1279-1286 19 Ricke J, Wust P, Wieners G et al. CT guided interstitial single fraction brachytherapy of lung tumors. Phase I results of a novel technique. Chest 2005; 127: 2237-2242 20 Seidensticker M, Wust P, Ruhl R et al. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol 2010; 5: 24 21 Ricke J, Wust P. Computed tomography – guided brachytherapy for liver cancer. Semin Radiat Oncol 2011; 21: 287-293 22 Schnapauff D, Denecke T, Grieser C et al. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol 2012; 35: 581-587 23 Bretschneider T, Peters N, Hass P et al. Update interstitielle Brachytherapie. Radiologe 2012; 52: 70-73 24 Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655 25 Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: Saunders; 1964: 50-64 26 Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649 27 Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol 1953; 39: 368-376 28 Streitparth F, Pech M, Böhmig M et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006; 65: 1479-1486 29 Liang SX, Zhu XD, Xu ZY et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance. Int J Radiat Oncol Bio Phys 2006; 65: 426-434
